Stem Cell Training, Inc. Announces Joint Venture with The Research Center in …PR Web (press release)Stem Cell Training Inc. has announced a new joint venture with The Research Center in Tissue Engineering and Cellular Therapy at Maimonides University in Buenos Aires to launch a post-graduate diploma program in cellular therapy and tissue … …read more &nbs… Continue reading
The Vatican’s New Clothes: Very Small Embryonic-Like Cells and Faith in …Religion & PoliticsThese cells were plastic enough to become any kind of cell within the human body. They were able to regenerate themselves indefinitely. First called “embryonic stem cells” in the 1980s after research moved from mouse to human cells, these magical …Joseph Purita, … Continue reading
Joseph Purita, M.D. and Maritza Novas, R.N., M.S.N of Stem Cell Training, Inc …PR Web (press release)Joseph Purita, M.D. and Maritza Novas, R.N., M.S.N. of Miami-based Stem Cell Training, Inc. were the featured keynote speakers at the prestigious 7th annual World Meeting of the Australian Academy for Anti-Aging Medicine in Melbourne, Australia, August …Stem Cell … Continue reading
樂威壯 com/news/url?sa=t&fd=R&usg=AFQjCNE9e9PzBv5BwJwHmqgYML5ZvCAZjg&url=http://www.digitaljournal.com/pr/1489819″>Stem Cell Training Inc. Announces Alliance with Far Eastern University to …DigitalJournal.comStem Cell Training, Inc., a division of the Global Stem Cells Group, today announced a newly formed alliance with Far Eastern University in Manila, Philippines for the advancement of stem call procedures. The alliance was established to train … …read more &nbs… Continue reading
Novel Antiviral Blocks CMV After Stem Cell TxMedPage TodayThe safety profile is a key feature, given that the antiviral approved for CMV infection prophylaxis in solid-organ transplant (valganciclovir [Valcyte]) is limited by myelosuppression, particularly in the setting of hematopoietic-cell transplantation …Novel drug prevents common viral disease in stem–cell transplant patients …Medical XpressAntiviral Protects Against CMV … Continue reading
Novel drug prevents common viral disease in stem–cell transplant patients …EurekAlert (press release)BOSTON — A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital …Antiviral Protects Against CMV … Continue reading
Antiviral Protects Against CMV After Stem Cell TransplantsMedscapeThe results show a significant reduction in the incidence of CMV events (which includes CMV disease and detectable CMV levels in the blood) in HCT recipients who were treated with CMX001. These CMV events were reported by 10% of patients on the new …Novel Antiviral Blocks CMV After … Continue reading
Novel drug prevents common viral disease in stem–cell transplant patients …Medical XpressA new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital indicates. …read more &nbs… Continue reading